← All comparisons

BPC-157 vs TB-500

Last updated

The key difference

BPC-157 is a 15-amino-acid fragment of a protein found in gastric juice, studied mostly in animals for gut, tendon, and ligament healing. TB-500 is derived from thymosin beta-4, a protein that regulates actin and cell migration, and is studied for tissue repair more broadly. Neither has substantial human trial data. Because their proposed mechanisms differ, they are often combined as the Wolverine stack, but a controlled rat study of Achilles tendon healing found the combination gave no additional benefit over either peptide alone.

Side by side

What it is
BPC-157A synthetic peptide fragment derived from a protein found in gastric juice, studied for its broad tissue-healing and cytoprotective effects. Popular in research for tendon, ligament, muscle, and gut repair.
TB-500A synthetic version of the active region of Thymosin Beta-4, a naturally occurring peptide that regulates cell migration and tissue repair. Researched for recovery, flexibility, and wound healing.
Research status
BPC-157Research chemical
TB-500Research chemical
Category
BPC-157Healing & Recovery
TB-500Healing & Recovery
Half-life
BPC-157Approximately 4-6 hours (estimated; rapidly cleared)
TB-500Long acting; effects attributed to systemic distribution over days
Routes
BPC-157subcutaneous, intramuscular, oral
TB-500subcutaneous, intramuscular
Reported dosing
BPC-157Research literature commonly references 200-500 mcg per administration, once or twice daily, in animal-equivalent and anecdotal human protocols. Not personal medical advice.
TB-500Research protocols often cite a loading phase of 2-2.5 mg twice weekly for several weeks, followed by a maintenance dose. Framed as research-literature ranges, not personal advice.
Studied for
BPC-157
  • Accelerated tendon, ligament, and muscle healing in animal models
  • Cytoprotective and ulcer-healing effects on the GI tract
  • Promotes angiogenesis (new blood vessel formation) at injury sites
  • May reduce inflammation in soft tissue and joints
TB-500
  • Promotes cell migration and tissue regeneration
  • Supports angiogenesis and wound closure in animal models
  • May improve flexibility and reduce muscle spasm
  • Anti-inflammatory effects on injured tissue
Side effects
BPC-157
  • Generally well tolerated in animal studies with low toxicity
  • Possible injection-site irritation, redness, or bruising
  • Occasional reports of mild nausea or fatigue (anecdotal)
  • Long-term human safety data is lacking
TB-500
  • Injection-site reactions (redness, swelling)
  • Possible transient head-rush or lethargy (anecdotal)
  • Theoretical concern with tumor angiogenesis
  • No long-term human safety data
Cited studies
BPC-1574 on its page
TB-5004 on its page

How BPC-157 works

BPC-157 is thought to upregulate angiogenesis by promoting VEGFR2 expression and activating the VEGFR2-Akt-eNOS signaling pathway, increasing blood vessel formation at injury sites. It modulates growth-hormone receptor expression in tendon fibroblasts and appears to influence the nitric oxide system. Animal studies also describe protective effects on the gut-brain axis and dopaminergic, serotonergic, and GABAergic systems.

Full BPC-157 profile →

How TB-500 works

TB-500 corresponds to the actin-binding domain of Thymosin Beta-4 and regulates actin polymerization, which governs cell migration, proliferation, and differentiation. By sequestering G-actin and promoting cytoskeletal remodeling, it enables cells such as endothelial and stem cells to migrate to sites of injury. It also upregulates genes associated with angiogenesis and downregulates inflammatory cytokines in preclinical models.

Full TB-500 profile →

Dosing shown is what research and community sources report, not a recommendation. For educational and research purposes only; not medical advice. How we source this

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.